arginine and Sclerosis, Systemic

arginine has been researched along with Sclerosis, Systemic in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19902 (9.52)18.7374
1990's3 (14.29)18.2507
2000's7 (33.33)29.6817
2010's7 (33.33)24.3611
2020's2 (9.52)2.80

Authors

AuthorsStudies
Bellando-Randone, S; Fioretto, BS; Kosalka-Wegiel, J; Manetti, M; Matucci-Cerinic, M; Romano, E; Rosa, I; Sticchi, E1
Dimitroulas, T; Doumas, M; Garyfallos, A; Karagiannis, A; Katsiki, N; Kitas, G; Loutradis, C; Malliari, A; Pagkopoulou, E; Soulaidopoulos, S1
Curtiss, P; Franks, AG; Lo Sicco, K; Schwager, Z1
Bartoszewicz, Z; Bienias, P; Ciurzyński, M; Demkow, U; Górska, E; Irzyk, K; Kostrubiec, M; Pruszczyk, P; Siwicka, M; Stelmaszczyk-Emmel, A1
Huang, XL; Wan, YN; Wang, J; Wang, YJ; Wang, YX; Yan, JW; Zhang, L; Zhao, JH1
Jiang, M; Liu, X; Luo, JY; Zhao, HP; Zhao, JJ1
Dimitroula, H; Dimitroulas, T; Giannakoulas, G; Karvounis, H; Koliakos, G; Settas, L; Sfetsios, T1
Blaise, S; Carpentier, PH; Cracowski, JL; Kom, GD; Maas, R; Roustit, M; Trocme, C1
Dimitroula, H; Dimitroulas, T; Giannakoulas, G; Karamitsos, T; Karvounis, H; Koliakos, G; Papadopoulou, K; Parcharidou, D; Settas, L1
Colaci, M; Ferri, C; Giuggioli, D; Sebastiani, M1
Dimitroula, H; Dimitroulas, T; Garyfallos, A; Giannakoulas, G; Karvounis, H; Koliakos, G; Papadopoulou, K; Parcharidou, D; Settas, L; Sfetsios, T; Styliadis, I1
Blüthner, M; Fritzler, MJ; Mahler, M1
Sallam, MM; Yassin, MM; Zamzam, ML1
Abraham, DJ; Black, CM; Bradley, N; Bruckdorfer, KR; Dooley, A; Gao, B; Jacobs, M1
Allanore, Y; Avouac, J; Boileau, C; Borderie, D; Kahan, A; Lemarechal, H; Wipff, J; Zerkak, D1
Freedman, RR; Girgis, R; Mayes, MD1
Belch, JJ; Khan, F1
Cho, CS; Hwang, SH; Kim, HY; Kim, WU; Min, JK; Park, SH; Youn, J1
Agostoni, A; Bassani, C; Biondi, ML; Bottasso, B; Cazzaniga, A; Cugno, M; Marasini, B1
Busch, H; Cook, RG; Lischwe, MA; Ochs, RL; Reddy, R; Reichlin, M; Tan, EM; Yeoman, LC1
Jones, JD; Ulrich, JA; Winkelmann, RK1

Reviews

3 review(s) available for arginine and Sclerosis, Systemic

ArticleYear
The clinical effects of l-arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:3

    Topics: Arginine; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Raynaud Disease; Scleroderma, Systemic; Vasodilation

2019
The association between systemic sclerosis, arginine and asymmetric dimethylarginine.
    Inflammation, 2015, Volume: 38, Issue:1

    Topics: Animals; Arginine; Case-Control Studies; Humans; Nitric Oxide; Scleroderma, Systemic

2015
Oxidative stress markers in blood in systemic sclerosis: A meta-analysis.
    Modern rheumatology, 2017, Volume: 27, Issue:2

    Topics: Arginine; Ascorbic Acid; Biomarkers; Case-Control Studies; Humans; Malondialdehyde; Nitric Oxide; Oxidative Stress; Scleroderma, Systemic; Superoxide Dismutase

2017

Trials

2 trial(s) available for arginine and Sclerosis, Systemic

ArticleYear
Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma.
    Lancet (London, England), 1999, Aug-28, Volume: 354, Issue:9180

    Topics: Adult; Arginine; Cold Temperature; Female; Fingers; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitroprusside; Raynaud Disease; Scleroderma, Systemic; Vasodilation

1999
Skin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral L-arginine supplementation.
    The Journal of rheumatology, 1999, Volume: 26, Issue:11

    Topics: Acetylcholine; Administration, Oral; Adolescent; Adult; Arginine; Child; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Humans; Male; Nitroprusside; Raynaud Disease; Regional Blood Flow; Scleroderma, Systemic; Skin; Vasodilation

1999

Other Studies

16 other study(ies) available for arginine and Sclerosis, Systemic

ArticleYear
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis.
    Clinical and experimental rheumatology, 2022, Volume: 40, Issue:10

    Topics: Arginine; Autoantibodies; Case-Control Studies; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Lung Diseases, Interstitial; Phosphoproteins; Polymorphism, Single Nucleotide; RNA Splicing Factors; RNA, Messenger; Scleroderma, Systemic; Serine; Serine-Arginine Splicing Factors

2022
The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Aged; Arginine; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nitric Oxide; Pilot Projects; Scleroderma, Systemic

2023
Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis.
    Clinical rheumatology, 2014, Volume: 33, Issue:1

    Topics: Adult; Aged; Antigens, CD; Arginine; Biomarkers; Case-Control Studies; Collagen; Echocardiography; Echocardiography, Doppler; Endoglin; Endothelin-1; Endothelium, Vascular; Female; Fibrosis; Humans; Lung Diseases; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Receptors, Cell Surface; Scleroderma, Systemic; Tissue Inhibitor of Metalloproteinase-1; Ventricular Function, Right

2014
Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension.
    Rheumatology (Oxford, England), 2008, Volume: 47, Issue:11

    Topics: Aged; Analysis of Variance; Arginine; Case-Control Studies; Echocardiography; Echocardiography, Doppler; Exercise Test; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Respiratory Function Tests; Scleroderma, Systemic

2008
Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis.
    The Journal of rheumatology, 2009, Volume: 36, Issue:5

    Topics: Arginine; Biomarkers; Endothelium, Vascular; Enzyme Inhibitors; Extracellular Matrix; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Raynaud Disease; Regional Blood Flow; Scleroderma, Systemic; Skin; Tissue Inhibitor of Metalloproteinase-1

2009
Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.
    The Journal of rheumatology, 2010, Volume: 37, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Arginine; Blood Flow Velocity; Echocardiography, Doppler; Endothelium, Vascular; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Scleroderma, Systemic; Ventricular Dysfunction, Left

2010
L-Arginine in pregnant scleroderma patients.
    Clinical rheumatology, 2010, Volume: 29, Issue:8

    Topics: Administration, Oral; Adult; Arginine; Female; Humans; Infant, Newborn; Injections, Intravenous; Pilot Projects; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Scleroderma, Systemic

2010
Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.
    Clinical rheumatology, 2010, Volume: 29, Issue:9

    Topics: Aged; Arginine; Biomarkers; Blood Pressure; Cross-Sectional Studies; Female; Follow-Up Studies; Heart Atria; Humans; Hypertension, Pulmonary; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prospective Studies; Pulmonary Artery; Scleroderma, Systemic; Ultrasonography; Ventricular Dysfunction, Right

2010
Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
    Arthritis research & therapy, 2005, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Antibody Specificity; Antigen-Antibody Reactions; Arginine; Arthritis, Rheumatoid; Autoantigens; Autoimmune Diseases; Cross Reactions; Dermatomyositis; DNA; Enzyme-Linked Immunosorbent Assay; Epitope Mapping; Epitopes; Epstein-Barr Virus Nuclear Antigens; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Mixed Connective Tissue Disease; Polymyositis; Reference Standards; Ribonucleoproteins, Small Nuclear; Scleroderma, Systemic; Sensitivity and Specificity; Sjogren's Syndrome; snRNP Core Proteins

2005
Implication of intercellular adhesion molecule-1 (ICAM-1) and serum N(G)-hydroxy-L-arginine (L-NHA) in the pathogenesis of systemic sclerosis.
    The Egyptian journal of immunology, 2003, Volume: 10, Issue:2

    Topics: Adult; Aged; Arginine; Biomarkers; Case-Control Studies; Female; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Scleroderma, Systemic; Skin; Solubility

2003
Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.
    Rheumatology (Oxford, England), 2006, Volume: 45, Issue:6

    Topics: Adult; Arginine; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Raynaud Disease; Scleroderma, Diffuse; Scleroderma, Limited; Scleroderma, Systemic; Severity of Illness Index

2006
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.
    Rheumatology (Oxford, England), 2008, Volume: 47, Issue:7

    Topics: Adult; Aged; Antigens, CD; Arginine; Biomarkers; Cross-Sectional Studies; Endoglin; Female; Humans; Male; Middle Aged; Neovascularization, Pathologic; Receptors, Cell Surface; Scleroderma, Systemic; Solubility; Vascular Endothelial Growth Factor A

2008
Association of the interleukin-4 receptor alpha variant Q576R with Th1/Th2 imbalance in connective tissue disease.
    Immunogenetics, 2000, Volume: 51, Issue:8-9

    Topics: Alleles; Arginine; Arthritis, Rheumatoid; Cells, Cultured; Connective Tissue Diseases; Genetic Variation; Glutamine; Humans; Lupus Erythematosus, Systemic; Lymphocyte Count; Point Mutation; Receptors, Interleukin-4; Scleroderma, Systemic; Sjogren's Syndrome; Th1 Cells; Th2 Cells

2000
L-arginine therapy in Raynaud's phenomenon?
    International journal of clinical & laboratory research, 1991, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Arginine; Endothelium, Vascular; Humans; Middle Aged; Nitric Oxide; Raynaud Disease; Scleroderma, Systemic; Skin Temperature; Tissue Plasminogen Activator; Vasodilation

1991
Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine.
    The Journal of biological chemistry, 1985, Nov-15, Volume: 260, Issue:26

    Topics: Amino Acid Sequence; Amino Acids; Animals; Antigens; Arginine; Autoantibodies; Cell Nucleolus; Fluorescent Antibody Technique; Histocytochemistry; Humans; Immunologic Techniques; Immunosorbent Techniques; Liver Neoplasms, Experimental; Microscopy, Electron; Molecular Weight; Physarum; Proteins; RNA; Scleroderma, Systemic

1985
Urinary amino acid excretion in patients with scleroderma.
    Mayo Clinic proceedings, 1971, Volume: 46, Issue:2

    Topics: Arginine; Aspartic Acid; Chelating Agents; Female; Glutamates; Histidine; Humans; Isoleucine; Leucine; Lysine; Male; Methionine; Phenylalanine; Renal Aminoacidurias; Scleroderma, Systemic; Threonine; Tyrosine; Valine

1971